John Bian to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications John Bian has written about Biosimilar Pharmaceuticals.
Connection Strength
0.118
-
Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
Score: 0.118
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.